April 23, 2020 / 5:32 PM / a month ago

BRIEF-Abionyx Pharma Reports Q1 Gross Cash Position Of 9.0 Million Euros

April 23 (Reuters) - Abionyx Pharma SA:

* Q1 GROSS CASH POSITION OF €9.0 MILLION AS AT MARCH 31TH, 2020

* DELAY IN ANNOUNCEMENT OF STRATEGIC PLAN

* CASH AND CASH EQUIVALENTS STOOD AT €9.0 MILLION AT 31 MARCH 2020

* FINANCIAL RESOURCES COMBINED WITH TEMPORARY ABSENCE OF FINANCIAL COMMITMENTS RELATED TO CLINICAL DEVELOPMENTS ALLOW CO TO ADAPT TO COVID-19 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below